###begin article-title 0
###xml 40 45 <span type="species:ncbi:9606">Human</span>
Maf1, a New Player in the Regulation of Human RNA Polymerase III Transcription
###end article-title 0
###begin p 1
Conceived and designed the experiments: NH JR TA. Performed the experiments: JR TA. Analyzed the data: JR TA. Wrote the paper: NH JR TA.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 159 164 <span type="species:ncbi:4932">yeast</span>
Human RNA polymerase III (pol III) transcription is regulated by several factors, including the tumor suppressors P53 and Rb, and the proto-oncogene c-Myc. In yeast, which lacks these proteins, a central regulator of pol III transcription, called Maf1, has been described. Maf1 is required for repression of pol III transcription in response to several signal transduction pathways and is broadly conserved in eukaryotes.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 92 100 92 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 224 232 220 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 237 244 233 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 13 18 <span type="species:ncbi:9606">human</span>
We show that human endogenous Maf1 can be co-immunoprecipitated with pol III and associates in vitro with two pol III subunits, the largest subunit RPC1 and the alpha-like subunit RPAC2. Maf1 represses pol III transcription in vitro and in vivo and is required for maximal pol III repression after exposure to MMS or rapamycin, treatments that both lead to Maf1 dephosphorylation.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 78 83 <span type="species:ncbi:9606">human</span>
These data suggest that Maf1 is a major regulator of pol III transcription in human cells.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 627 630 627 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Paule1">[1]</xref>
###xml 632 635 632 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-White1">[2]</xref>
###xml 1030 1033 1030 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-White1">[2]</xref>
###xml 1035 1038 1035 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-FeltonEdkins1">[3]</xref>
###xml 829 834 <span type="species:ncbi:9606">human</span>
RNA polymerase III (pol III) is responsible for the transcription of various short genes encoding untranslated RNAs involved in the maturation of other RNA molecules and in protein biosynthesis. These untranslated RNAs are essential for cell growth and proliferation, and are often abundant and stable. Consequently, pol III transcription is highly regulated, being high in rapidly dividing cells, which need to duplicate a large number of pol III transcripts in a limited time, and low in resting cells, where the demand for pol III activity is probably largely limited to the replacement of slowly decaying pol III RNAs (see [1], [2], and references therein). Moreover, pol III transcription is rapidly inhibited after a number of stresses that arrest cell growth and/or division, such as DNA damage or rapamycin treatment. In human cells so far, the main known pol III regulation mechanisms involve tumor suppressors and proto-oncogenes whose first identified transcription functions were in the regulation of pol II promoters [2], [3].
###end p 9
###begin p 10
###xml 445 448 445 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Paule1">[1]</xref>
###xml 450 453 450 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Geiduschek1">[4]</xref>
###xml 455 458 455 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Schramm1">[5]</xref>
###xml 1033 1034 1033 1034 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 1194 1197 1194 1197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Paule1">[1]</xref>
###xml 1199 1202 1199 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Geiduschek1">[4]</xref>
###xml 1204 1207 1204 1207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Schramm1">[5]</xref>
###xml 107 112 <span type="species:ncbi:9606">human</span>
Pol III promoters use dedicated transcription factors as well as factors also used by pol II promoters. In human cells and their viruses, there are three main types of pol III promoters, the gene-internal type 1 promoter of the 5S small ribosomal RNA gene, the gene-internal type 2 promoters of the transfer RNA (tRNA) or Adenovirus 2 (Ad2) VAI genes, and the gene-external type 3 promoters of, for example, the U6 snRNA, 7SK, and H1 genes (see [1], [4], [5] for reviews). On type 1 promoters, the initial binding of the zinc protein TFIIIA allows the successive recruitment of the multisubunit complex TFIIIC and the Brf1-TFIIIB activity, composed of the TATA box binding protein TBP, the TFIIB-related factor Brf1, and the SANT domain protein Bdp1. Type 2 promoters recruit the same factors except that in this case, the promoter elements recruit TFIIIC directly, without the help of TFIIIA. The core type 3 promoters are composed of a proximal element (PSE) and a TATA box that recruit, respectively, the multisubunit complex SNAPc and the TBP component of Brf2-TFIIIB, an activity similar to Brf1-TFIIIB except that Brf1 is replaced by another TFIIB-related factor referred to as Brf2 (see [1], [4], [5] for reviews).
###end p 10
###begin p 11
###xml 170 173 170 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-White1">[2]</xref>
###xml 175 178 175 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-FeltonEdkins1">[3]</xref>
###xml 180 183 180 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-White2">[6]</xref>
###xml 424 427 424 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-White3">[7]</xref>
###xml 428 431 428 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Sutcliffe1">[9]</xref>
###xml 476 477 476 477 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 559 563 559 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Hirsch1">[10]</xref>
###xml 565 569 565 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Hirsch2">[11]</xref>
###xml 711 712 711 712 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 712 716 712 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Cairns1">[12]</xref>
###xml 717 721 717 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Gridasova1">[14]</xref>
Pol III transcription in mammalian cells is repressed by the tumor suppressors Rb and P53, which both affect transcription from all three types of pol III promoters (see [2], [3], [6] for reviews). Rb down-.regulates type 1 and 2 promoters by binding through its large pocket domain to Brf1-TFIIIB and preventing interactions with TFIIIC and pol III that are presumably required for efficient transcription complex assembly [7]-[9]. At type 3 promoters, it interacts with SNAPc on DNA and inactivates transcription at a step subsequent to pol III recruitment [10], [11]. The mechanisms by which P53 down-regulates transcription are less well characterized but the protein is known to associate with TBP and SNAPc[12]-[14].
###end p 11
###begin p 12
###xml 119 143 119 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 143 147 143 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Upadhya1">[15]</xref>
###xml 215 228 215 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. cerevisiae</italic>
###xml 283 289 283 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">maf1-1</italic>
###xml 372 376 372 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Murawski1">[16]</xref>
###xml 381 387 381 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">maf1-1</italic>
###xml 589 593 589 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Pluta1">[17]</xref>
###xml 886 890 886 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Upadhya1">[15]</xref>
###xml 896 900 896 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Willis1">[18]</xref>
###xml 119 143 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 215 228 <span type="species:ncbi:4932">S. cerevisiae</span>
Recently, a key player in the down-regulation of pol III transcription after stress or at quiescence was discovered in Saccharomyces cerevisiae[15]. This repressor, referred to as Maf1, was originally identified in S. cerevisiae by the isolation of a temperature-sensitive mutation, maf1-1, that affected tRNA suppressor efficiency and interacted genetically with pol III [16]. In maf1-1 cells, tRNA levels were elevated, and pol III transcription was much more active in extracts from such cells than in extracts from wild-type cells, suggesting that Maf1 represses pol III transcription [17]. A key advance was the subsequent characterization of Maf1 as a common component of at least three signaling pathways that lead to pol III transcription repression, the secretory defect signaling pathway, the target of rapamycin (TOR) signaling pathway, and the DNA damage signaling pathway ([15], see [18] for a review).
###end p 12
###begin p 13
###xml 12 16 12 16 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-OficjalskaPham1">[19]</xref>
###xml 18 22 18 22 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Roberts1">[20]</xref>
###xml 92 96 92 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Geiduschek2">[21]</xref>
###xml 316 320 316 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Moir1">[22]</xref>
###xml 554 558 554 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-OficjalskaPham1">[19]</xref>
###xml 560 564 560 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Roberts1">[20]</xref>
###xml 759 763 759 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-OficjalskaPham1">[19]</xref>
###xml 1032 1036 1032 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Roberts1">[20]</xref>
###xml 1038 1046 1038 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 1284 1288 1284 1288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Desai1">[23]</xref>
###xml 132 137 <span type="species:ncbi:4932">yeast</span>
Recent work [19], [20] has considerably advanced our understanding of the role of Maf1 (see [21] for a review). In actively growing yeast cells, Maf1 is present in both the nucleus and the cytoplasm, and a large fraction of Maf1 is phosphorylated, at least in part by PKA, whose activity counteracts Maf1 repression [22]. Upon exposure of the cells to various stresses, Maf1 is dephosphorylated in a manner dependent on PP2A and translocates to the nucleus, where it occupies pol III promoters as determined by genome-wide chromatin immunoprecipitations [19], [20]. The dephosphorylated form of Maf1 can associate with pol III, and recombinant Maf1 can bind to a protein fragment corresponding to the N-terminal 235 amino acids of the largest pol III subunit [19]. Yet, in chromatin immunoprecipitations, the increase in Maf1 signal at pol III promoters after stress is accompanied by a decrease in pol III signal, perhaps reflecting a change in polymerase conformation upon Maf1 binding that prevents efficient crosslinking to DNA [20]. In vitro, Maf1 is capable of preventing assembly of a transcription complex by binding to Brf1, suggesting that in addition to inhibiting transcription through binding to pol III, Maf1 can also prevent the assembly of new transcription complexes [23]. These results suggest that Maf1 is a central player in transduction pathways that lead to repression of pol III transcription, and give the first indications of the mechanisms by which Maf1 inhibits pol III transcription.
###end p 13
###begin p 14
###xml 89 93 89 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Pluta1">[17]</xref>
###xml 287 295 287 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 300 307 300 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 584 591 584 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 596 604 596 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 670 671 670 671 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 17 22 <span type="species:ncbi:4932">yeast</span>
###xml 231 236 <span type="species:ncbi:9606">human</span>
###xml 433 438 <span type="species:ncbi:4932">yeast</span>
###xml 795 800 <span type="species:ncbi:4932">yeast</span>
###xml 810 815 <span type="species:ncbi:9606">human</span>
The discovery of yeast Maf1, and the observation that Maf1 is conserved in other species [17], raise the important question of whether Maf1 plays a similarly central role in pol III repression in mammalian cells. Here we show that human Maf1 is a repressor of pol III transcription both in vitro and in vivo. It down-regulates transcription non only from type 1 and 2 promoters, but also from type 3 promoters, which do not exist in yeast, and can do so in non-transformed cells as well as in transformed cells that do not respond to some stress signals. Maf1 associates with pol III in vivo and in vitro. Of all the individual subunits of Brf1-TFIIIB, Brf2-TFIIIB, SNAPc, and pol III, Maf1 associates weakly with Brf1 and RPC1, the largest subunit of pol III, and strongly with RPAC2. Like the yeast protein, human Maf1 is phosphorylated and becomes largely dephosphorylated after stress, and it is the dephosphorylated form of Maf1 that associates with pol III. The results suggest that Maf1 is a major player in repression of pol III transcription in mammalian cells.
###end p 14
###begin title 15
Results
###end title 15
###begin title 16
###xml 72 80 72 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Maf1 represses transcription from type I, II, and III pol III promoters in vitro
###end title 16
###begin p 17
###xml 405 409 405 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Ullu1">[24]</xref>
###xml 499 516 499 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000134-g001">Figures 1A and 1C</xref>
###xml 1404 1412 1404 1412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 19 24 <span type="species:ncbi:9606">human</span>
###xml 663 670 <span type="species:ncbi:562">E. coli</span>
To examine whether human Maf1 is a negative regulator of pol III transcription, we first tested its effects on pol III transcription in a HeLa cell extract. We tested transcription from the 5S type 1 promoter, the Adenovirus 2 (Ad2) VAI type 2 promoter, and the U6 type 3 promoter. We also tested the 7SL promoter, a mixed type 2 promoter with activating elements upstream of the transcription start site [24], as well as the Ad2 major late (ML) promoter, which is recognized by pol II. As shown in Figures 1A and 1C, all templates were efficiently transcribed (compare lanes 1 and 2). However, upon addition of increasing amounts of recombinant Maf1 produced in E. coli, transcription from all types of pol III promoters, but not from the pol II Ad2 ML promoter, was severely depressed (lanes 3-6). In contrast, addition of increasing amounts of similarly prepared Brf2, which is not involved in transcription from type 1 and 2 pol III promoters nor from pol II promoters, did not repress 5S, VAI, 7SL, and ML transcription, and addition of increasing amounts of similarly prepared GST did not decrease U6 transcription (lanes 7-10). Panels B and D show that similar amounts of recombinant Maf1, Brf2, and GST were used in these experiments as determined by coomassie blue-staining of protein gels. Thus, Maf1 efficiently and specifically represses pol III transcription from type 1, 2, and 3 promoters in vitro, but not pol II transcription from the Ad2 ML promoter.
###end p 17
###begin p 18
###xml 60 68 60 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 78 86 78 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 249 253 249 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Desai1">[23]</xref>
###xml 307 308 307 308 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 335 339 335 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Saxena1">[25]</xref>
###xml 601 609 601 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1022 1031 1022 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000134-g001">Figure 1E</xref>
###xml 7 12 <span type="species:ncbi:4932">yeast</span>
###xml 391 396 <span type="species:ncbi:9606">human</span>
In the yeast system, Maf1 can repress pol III transcription in vitro, and the in vitro effect is attributed mainly to inhibition of TFIIIB-promoter DNA complex assembly, specifically Brf1 recruitment, as well as to inhibition of pol III recruitment [23]. We can monitor assembly of TBP, Brf2, Bdp1, and SNAPc on a U6 promoter by EMSAs [25], and so we checked whether addition of recombinant human Maf1 inhibited formation of either the four-factor complex or various subcomplexes on the U6 promoter. We were unable to detect inhibition of complex formation by Maf1, suggesting that Maf1 inhibition of in vitro U6 transcription is not due to effects on transcription factor assembly (data not shown). We tested, therefore, whether recombinant Maf1 could associate with pol III in the HeLa cell transcription extract. We incubated nickel beads in extracts either not supplemented- or supplemented- with His-tagged Maf1, and checked the retained material for the presence of RPC1, the largest subunit of pol III. As shown in Figure 1E, RPC1 was specifically recovered from extracts supplemented with Maf1 (compare lanes 2 and 3). This is consistent with a repression mechanism involving Maf1 association with pol III.
###end p 18
###begin title 19
###xml 110 118 110 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Endogenous Maf1 associates with pol III and Brf1, and Maf1 can associate with two individual pol III subunits in vitro
###end title 19
###begin p 20
###xml 495 504 495 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000134-g002">Figure 2A</xref>
###xml 800 804 800 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Desai1">[23]</xref>
###xml 897 906 897 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000134-g002">figure 2A</xref>
###xml 742 747 <span type="species:ncbi:4932">yeast</span>
###xml 789 794 <span type="species:ncbi:4932">yeast</span>
###xml 825 830 <span type="species:ncbi:9606">human</span>
###xml 965 970 <span type="species:ncbi:9606">human</span>
The observation that Maf1 can associate with pol III when added to a transcription extract prompted us to test whether pol III could be immunoprecipitated with endogenous Maf1. We performed immunoprecipitations from HeLa whole cell extracts with either an anti-Maf1 or, as a control, an anti-GAPDH, antibody. Input material (whole cell extract, WCE), flow-through, wash, and material eluted from the beads were then analyzed by immunoblotting with an antibody directed against RPC1. As shown in Figure 2A, RPC1 was clearly retained on the anti-Maf1, but not the anti-GAPDH, beads, indicating that endogenous Maf1 can associate with pol III. We also checked the precipitated material for the presence of the transcription factor Brf1, because yeast Maf1 has been reported to associate with yeast Brf1 [23]. Indeed, endogenous human Brf1 was specifically present in the anti-Maf1 immunoprecipitate (figure 2A), raising the possibility that it interacts directly with human Maf1.
###end p 20
###begin p 21
###xml 168 169 168 169 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 258 266 258 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 287 289 287 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 403 431 403 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000134-g002">Figure 2, panels B, D, and E</xref>
###xml 1014 1018 1014 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-OficjalskaPham1">[19]</xref>
###xml 1028 1032 1028 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Desai1">[23]</xref>
###xml 1374 1383 1374 1383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000134-g002">Figure 2A</xref>
###xml 1473 1474 1473 1474 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 961 966 <span type="species:ncbi:4932">yeast</span>
###xml 1000 1005 <span type="species:ncbi:4932">yeast</span>
###xml 1096 1101 <span type="species:ncbi:9606">human</span>
We then explored the ability of Maf1 to associate with individual pol III subunits and transcription factors. The 17 pol III subunits, as well as the 5 subunits of SNAPc, and the Brf1- and Brf2-TFIIIB components Bdp1, Brf2, Brf1, and TBP were all translated in vitro in the presence of [35S] methionine and tested for association with recombinant GST-Maf1 or GST alone immobilized on beads. As shown in Figure 2, panels B, D, and E, of these 26 proteins, only three were significantly retained on the GST-Maf1 beads, namely the largest pol III subunit RPC1 and the pol I and pol III subunit RPAC2 (AC19) (panel B), as well as Brf1 (panel D). Although the interactions with RPC1 and Brf1 were weak, they were clearly above background. The interactions with the pol III subunits RPC1 and RPAC2 were resistant to treatment with RNase A and DNase I (panel C) and are thus unlikely to be mediated by RNA or DNA. These results are consistent with the associations of yeast Maf1 with the largest subunit of yeast pol III [19] and Brf1 [23] observed previously. They indicate that when components of the human pol III transcription machinery are systematically tested, only one additional polypeptide, RPAC2, associates with Maf1, but this association is by far the strongest one and may thus be responsible for most of the observed association between endogenous Maf1 and pol III (Figure 2A). The lack of association with any of the factors used by type 3 promoters, i.e. all SNAPc subunits, Bdp1, TBP, and Brf2, is consistent with the idea that Maf1 does not affect assembly of these factors on the U6 promoter.
###end p 21
###begin p 22
###xml 144 153 144 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000134-g002">Figure 2F</xref>
###xml 244 248 244 248 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1-81</sup>
###xml 304 309 304 309 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1-142</sup>
###xml 580 584 580 584 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;81</sup>
###xml 671 676 671 676 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;142</sup>
Maf1 contains three region of high phylogenetic sequence conservation designated the A, B, and C boxes, followed by an acidic tail. As shown in Figure 2F, we generated truncated versions of the protein either containing the A box sequence (Maf11-81) or containing both the A and the B box sequences (Maf11-142 ), fused to an N-terminal GST tag, and checked their ability to retain RPC1, Brf1, and RPAC2 in a GST pull-down experiment as above. As before, all three proteins associated with full-length Maf1 (not shown). However, whereas RPC1 and RPAC2 could associate with the Maf11-81 truncated version containing just the A box, Brf1 only associated with the longer Maf11-142 truncated version, containing both the A and the B boxes. Thus, whereas the first 81 amino acids are sufficient for association with pol III subunits, the B box is required for association with Brf1, indicating that Maf1 interacts with pol III and Brf1 via different domains.
###end p 22
###begin title 23
Knock-down of endogenous Maf1 in non-transformed and transformed cells results in higher levels of unstable tRNA precursors
###end title 23
###begin p 24
###xml 320 329 320 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000134-g003">Figure 3A</xref>
###xml 695 698 695 698 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tyr</sup>
###xml 709 713 709 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-MacPherson1">[26]</xref>
###xml 158 163 <span type="species:ncbi:9606">human</span>
###xml 219 224 <span type="species:ncbi:9606">human</span>
To examine the effects of Maf1 in cultured cells, we used RNA interference (RNAi) to decrease the amounts of endogenous Maf1. We first used a non-transformed human lung fibroblast cell line IMR-90 stably expressing the human Tert protein (IMR-90Tert, a gift from G.J. Hannon, Cold Spring Harbor Laboratory). As shown in Figure 3A, Maf1 mRNA analysis with reverse transcription followed by quantitative real-time polymerase chain reaction (RT-qPCR) showed a severe decrease after transfection with two different silencing RNAs (siRNAs) (# 2 and # 3) directed against Maf1, but not after transfection with a control siRNA (black bars). Strikingly, the levels of the intron-containing unstable tRNATyr precursor [26] increased by about two fold (yellow bars), whereas those of the pol II-transcribed Glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) mRNA varied very little (blue bars).
###end p 24
###begin p 25
###xml 126 135 126 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000134-g003">Figure 3B</xref>
###xml 400 403 400 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tyr</sup>
###xml 412 415 412 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leu</sup>
###xml 427 431 427 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-MacPherson1">[26]</xref>
###xml 433 437 433 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Green1">[27]</xref>
###xml 448 484 448 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000134-g003">Figure 3C (middle and bottom panels)</xref>
###xml 665 669 665 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Yuo1">[28]</xref>
###xml 74 79 <span type="species:ncbi:9606">human</span>
We then examined the effect of reducing levels of Maf1 in the transformed human embryonic kidney (HEK) 293 cells. As shown in Figure 3B, three different siRNAs directed against Maf1 (#A2, #2, and #3), but not a control siRNA, reduced Maf1 protein by more than 80% (compare lanes 2-4 to lanes 1 and 5). A northern blot analysis of total RNA with a probe hybridizing to the intronic regions of the tRNATyr and tRNALeu precursors [26], [27], shown in Figure 3C (middle and bottom panels), revealed that in all cases where Maf1 protein levels were decreased, the levels of tRNA precursors were increased. When normalized for the levels of the pol II U2 snRNA precursor [28](upper panel), which varied little, tRNA precursor levels increased 2 to 2.5 fold. Thus, reducing intracellular levels of Maf1 results in increased levels of precursor tRNAs, consistent with the idea that Maf1 is a repressor of pol III transcription.
###end p 25
###begin title 26
Knock-down of endogenous Maf1 results in higher pol III transcription after MMS treatment
###end title 26
###begin p 27
###xml 404 408 404 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Hay1">[29]</xref>
###xml 572 581 572 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000134-g004">Figure 4A</xref>
###xml 1470 1479 1470 1479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000134-g004">Figure 4B</xref>
###xml 3 8 <span type="species:ncbi:4932">yeast</span>
###xml 124 129 <span type="species:ncbi:9606">human</span>
In yeast cells, Maf1 is essential for down-regulation of pol III transcription after stress. To examine the role of Maf1 in human cells after stress, we first treated both transformed HEK 293 and non-transformed IMR-90Tert cells with methane methylsulfonate (MMS), an alkylating agent that causes DNA damage, or rapamycin, an antibiotic that inhibits the TOR kinase and mimicks nutrient deprivation (see [29]). However, MMS did not significantly reduce pol III transcription in the transformed HEK 293 cells (data not shown), and we therefore focused on IMR-90Tert cells. Figure 4A shows an RT-qPCR analysis of Maf1 mRNA levels after transfection of these cells with various siRNAs. MMS treatment had little effect on Maf1- (10% decrease) and GAPDH- (20% decrease) mRNA levels, and so these levels are set at 100% in the figure (left: no siRNA) to facilitate visual comparison of the siRNA effects. Transfection of two different siRNAs directed against Maf1 (# 3 and # 2), but not of a control siRNA, decreased Maf1 mRNA levels to less than 20%, both in the absence or presence of MMS (black and grey bars). By comparison, the levels of GAPDH mRNAs varied little, and not in a consistent manner (blue and white bars). We then analyzed a constant amount of total RNA from these cells on a Bioanalyzer (Applied Biosystems), which separates large RNAs from the small RNA population consisting largely of pol III transcripts, in particular mature, stable tRNAs. As shown in Figure 4B, there was little change in the global amounts of small RNAs 12 h and 15 h after MMS treatment in untransfected cells or cells transfected with the control siRNA (lanes 3, 4, 9, and 10). This lack of apparent decrease after MMS treatment probably reflects the great stability of most mature pol III transcripts. In cells transfected with siRNAs directed against Maf1, however, there was an increase in the amounts of small RNAs after MMS treatment (lanes 5-8), as well as after rapamycin treatment (data not shown), consistent with the idea that when Maf1 levels are diminished, pol III transcription continues even after stress.
###end p 27
###begin p 28
###xml 359 368 359 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000134-g004">Figure 4C</xref>
###xml 1102 1110 1102 1110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000134-g003">Figure 3</xref>
###xml 1416 1421 <span type="species:ncbi:9606">human</span>
To confirm the attenuation of pol III repression after MMS treatment, and to determine whether it affected a type 3 promoter, we created an IMR-90Tert cell line containing an integrated construct in which the U6 promoter directs the synthesis of an unstable RNA, whose levels, therefore, better reflect transcriptional activity (see Experimental Procedures). Figure 4C shows an RNAse T1 protection analysis of these U6 promoter-directed transcripts. As expected, they can be detected in the IMR-90Tert U6 reporter cell line, referred to as the IMR-C35 cell line, but not in the parent cell line (compare lane 1 with, for example, lanes 2 and 8). In untransfected cells and cells transfected with the control siRNA, U6 promoter-directed transcription was severely diminished after MMS treatment (compare lane 2 to lane 3, and lane 8 to lane 9), as expected after transcription repression of an unstable RNA. After Maf1 levels were decreased by RNAi, the levels of U6 transcription were either not, or only modestly, increased in the absence of MMS, suggesting that unlike the tRNA promoters analyzed in Figure 3, the much weaker U6 promoter is not repressed by Maf1 in actively dividing cells (compare lanes 2 and 8 to lanes 4 and 6). However, after MMS treatment, the decrease of Maf1 levels prevented repression of U6 transcription (compare lanes 5 and 7 to lanes 3 and 9). Collectively, these results suggest that human Maf1 is required for repression of pol III transcription after DNA damage.
###end p 28
###begin title 29
Maf1 is phosphorylated in mammalian cells
###end title 29
###begin p 30
###xml 120 124 120 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-OficjalskaPham1">[19]</xref>
###xml 126 130 126 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Roberts1">[20]</xref>
###xml 562 583 562 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000134-g005">Figure 5, upper panel</xref>
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
###xml 160 165 <span type="species:ncbi:9606">human</span>
###xml 277 282 <span type="species:ncbi:9606">human</span>
###xml 459 463 <span type="species:ncbi:9913">Calf</span>
Yeast Maf1 is a phosphoprotein that is rapidly dephosphorylated under stress conditions that lead to pol III repression [19], [20]. We therefore tested whether human Maf1 is phosphorylated, and whether its phosphorylation status changes under stress conditions. We subjected a human embryonic kidney 293 stable cell line expressing HA-tagged Maf1 to rapamycin or MMS treatment. Nuclear extract from untreated and treated cells was prepared and incubated with Calf Intestine Alkaline Phosphatase (CIAP), either without or with phosphatase inhibitors. As shown in Figure 5, upper panel, immunoblotting of equal amounts of nuclear extracts with an anti-HA antibody showed several bands, in particular one (indicated by a line) migrating close to recombinant flag-Maf1-HT (lane 5) and a slower migrating tight doublet (indicated by an arrowhead) (lane 1). The tight doublet disappeared while the lower band increased in intensity after treatment with CIAP in the absence, but no the presence, of phosphatase inhibitors (compare lanes 2 and 3). This indicates that the tight doublet is a phosphorylated form of Maf1. Significantly, in extracts from cells treated with rapamycin or MMS, only the fast-migrating form of Maf1 comigrating with recombinant Maf1 was observed (middle and bottom panels). This fast migrating form may be entirely dephosphorylated or may contain phosphate groups that do not affect its migration. Similar results were obtained with whole cell rather than nuclear extracts (data not shown).
###end p 30
###begin p 31
###xml 514 523 514 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000134-g005">Figure 5B</xref>
###xml 740 745 <span type="species:ncbi:9606">human</span>
###xml 990 995 <span type="species:ncbi:9606">human</span>
We then proceeded to determine whether Maf1 is phosphorylated in the non-transformed IMR-90Tert cells, and which form of Maf1 binds to pol III. We prepared nuclear extracts from IMR-90Tert cells expressing HA-tagged Maf1. To avoid partial dephosphorylation of Maf1, we prepared the extract in the presence of phosphatase inhibitors. The extract was then used as the starting material in an immunoprecipitation with an anti-RPC1 antibody, and the immmunoprecipitate was probed for the presence of Maf1. As shown in Figure 5B, several forms of Maf1 were present in the starting material, and only the minor fastest migrating form was found in the anti-RPC1 immunoprecipitate. Together, the data indicate that tagged Maf1 is phosphorylated in human cells, that it is at least partially dephosphorylated under stress conditions, and that it is the dephosphorylated form that associates with pol III. Thus, pol III repression and association with pol III are linked to Maf1 dephosphorylation in human cells.
###end p 31
###begin title 32
Discussion
###end title 32
###begin p 33
###xml 125 133 125 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 173 190 173 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000134-g001">Figures 1A and 1C</xref>
###xml 282 290 282 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000134-g003">Figure 3</xref>
###xml 607 611 607 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Moir1">[22]</xref>
###xml 732 741 732 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000134-g004">Figure 4C</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 519 524 <span type="species:ncbi:4932">yeast</span>
Human Maf1 is a repressor of pol III transcription, as suggested by the observations that it represses pol III transcription in vitro when added to transcription reactions (Figures 1A and 1C) and that its knock-down in cells results in higher levels of short-lived tRNA precursors (Figure 3). This last result, observed in actively dividing cells, suggests that in such cells, there is some Maf1 activity that keeps pol III transcription, in particular from tRNA promoters, in check, consistent with the observation in yeast that some Maf1 is nuclear and active even when the cells are in exponential phase [22]. On the other hand, weaker promoters such as the U6 promoter may not be partially repressed in actively dividing cells (Figure 4C).
###end p 33
###begin p 34
###xml 132 136 132 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-OficjalskaPham1">[19]</xref>
###xml 138 142 138 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Roberts1">[20]</xref>
###xml 205 209 205 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Desai1">[23]</xref>
###xml 267 268 267 268 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 408 416 408 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000134-g002">Figure 2</xref>
###xml 502 510 502 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 537 546 537 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000134-g001">Figure 1E</xref>
###xml 593 602 593 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000134-g002">Figure 2A</xref>
###xml 686 695 686 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000134-g002">Figure 2B</xref>
###xml 1140 1144 1140 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Desai1">[23]</xref>
###xml 3 8 <span type="species:ncbi:4932">yeast</span>
###xml 303 308 <span type="species:ncbi:9606">human</span>
###xml 1126 1131 <span type="species:ncbi:4932">yeast</span>
###xml 1237 1242 <span type="species:ncbi:9606">human</span>
In yeast, Maf1 represses transcription by at least two mechanisms: by acting on pol III itself, probably already bound to promoters [19], [20], and by preventing assembly of Brf1 into initiation complexes [23]. We could not see any effects of Maf1 in assembly of SNAPc, TBP, Brf2 and Bdp1 on the type 3 human U6 promoter. Moreover, Maf1 did not associate with any of these proteins in a GST pull-down assay (Figure 2). We could, however, detect association of exogenously added Maf1 with pol III under in vitro transcription conditions (Figure 1E), association of endogenous Maf1 and pol III (Figure 2A), and association with two individual pol III subunits in the GST pull-down assay (Figure 2B). This suggests that at least for type 3 promoters, where we tested assembly of all the factors required to recruit a pol III complex, Maf1 does not act on formation of the promoter-bound pol III-recruiting complex but rather by binding to pol III. On the other hand, we detected association of Maf1 with endogenous Brf1, as well as a weak association in the GST pull-down assay. This association parallels that observed with the yeast protein [23] and suggests that Maf1 may have an effect on formation of the pol III-recruiting complex on human type 1 and 2 promoters, which use Brf1- rather than Brf2- TFIIIB. Interestingly, the Maf1 region required for association with Brf1 is different from that required for association with pol III subunits.
###end p 34
###begin p 35
###xml 88 92 85 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Pluta1">[17]</xref>
###xml 251 255 248 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-OficjalskaPham1">[19]</xref>
###xml 452 461 445 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000134-g002">Figure 2B</xref>
###xml 607 611 600 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Cramer1">[30]</xref>
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
###xml 42 49 <span type="species:ncbi:562">E. coli</span>
###xml 279 284 <span type="species:ncbi:9606">human</span>
###xml 323 328 <span type="species:ncbi:9606">human</span>
###xml 393 400 <span type="species:ncbi:562">E. coli</span>
###xml 487 492 <span type="species:ncbi:9606">human</span>
###xml 674 681 <span type="species:ncbi:562">E. coli</span>
###xml 857 862 <span type="species:ncbi:4932">yeast</span>
Yeast Maf1 interacts genetically with the E. coli beta'-like largest subunit of pol III [17], and this has prompted the testing of whether the two proteins associate with each other. Indeed, Maf1 associates with the first 235 amino acids of C160/RPC1 [19]. However, at least for human Maf1, a systematic testing of all the human pol III subunits indicates a much stronger interaction with the E. coli alpha-like subunit AC19/RPAC2 as compared to RPC1 (Figure 2B). A superposition of the human RPC1 and RPAC2 sequences on those of the paralogue pol II subunits RPB1 and RPB11 in the pol II crystal structure [30] indicates that, as expected for subunits corresponding to the E. coli RNA polymerase beta'- and alpha-like subunits, the two polypeptides contact each other. Nevertheless, the first 235 amino acids of RPC1 are not close to RPAC2. Thus, if as in yeast, the RPC1 association with Maf1 is through the first 235 RPC1 amino acids, it is not clear that RPC1 and RPAC2 are contacted at the same time.
###end p 35
###begin p 36
###xml 182 190 182 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000134-g004">Figure 4</xref>
###xml 341 349 341 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000134-g003">Figure 3</xref>
###xml 735 744 735 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000134-g005">Figure 5A</xref>
###xml 956 960 956 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Moir1">[22]</xref>
###xml 56 61 <span type="species:ncbi:9606">human</span>
###xml 624 629 <span type="species:ncbi:9606">human</span>
###xml 750 755 <span type="species:ncbi:4932">yeast</span>
Maf1 is involved in at least two repression pathways in human cells, the MMS and rapamycin pathways, because knock-down of Maf1 diminishes pol III repression after these treatments (Figure 4 and data not shown). Interestingly, Maf1 is active in transformed 293 cells, since knock-down of Maf1 in these cells increases pol III transcription (Figure 3), even though we find that MMS treatment does not lead to the rapid pol III repression seen in IMR-90Tert cells (data not shown). This indicates that even though some signaling pathways to Maf1 are lost in these cells, the Maf1 protein itself is still active. Intriguingly, human Maf1 is phosphorylated in 293 cells and phosphorylation is lost after both MMS and rapamycin treatments (Figure 5A). In yeast, Maf1 dephosphorylation is linked to nuclear localization, but nuclear localization is not sufficient for transcription repression, indicating that other signals are necessary to activate the protein [22]. This suggests that in 293 cells, Maf1 may localize correctly to the nucleus after MMS treatment but that another signal, lost in 293 cells, is required for Maf1 activation by DNA damage. Maf1 could potentially be a tumor suppressor. It will be interesting to determine whether in some other tumor cells, the Maf1 protein itself, rather than signaling to Maf1, is debilitated.
###end p 36
###begin title 37
Materials and Methods
###end title 37
###begin title 38
Plasmids and constructs
###end title 38
###begin p 39
###xml 117 121 117 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1-81</sup>
###xml 130 135 130 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1-142</sup>
###xml 327 331 327 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Tanaka1">[31]</xref>
###xml 471 475 471 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Schenk1">[32]</xref>
###xml 546 550 546 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Lobo1">[33]</xref>
###xml 590 594 590 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Ullu1">[24]</xref>
###xml 603 607 603 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Little1">[34]</xref>
###xml 620 624 620 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Lobo2">[35]</xref>
###xml 680 684 680 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Lobo2">[35]</xref>
###xml 964 968 961 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Lobo1">[33]</xref>
###xml 30 35 <span type="species:ncbi:9606">human</span>
###xml 62 67 <span type="species:ncbi:9606">human</span>
###xml 351 358 <span type="species:ncbi:562">E. coli</span>
###xml 825 830 <span type="species:ncbi:9606">human</span>
The Maf1 coding region from a human cDNA encoding full-length human Maf1 (GenBank accession number NM_032272) or Maf11-81 and Maf11-142 fragments were amplified by PCR using specific primers and inserted into various vectors. For expression in mammalian cells as N-terminal HA tag fusions, it was inserted into the pCGN vector [31]. For expression in E. coli as an N-terminal Flag and C-terminal His tag fusion, or as an N-terminal GST fusion, it was inserted into pSBet [32] derivatives. All clones were verified by DNA sequencing. pU6/Hae/RA.2 [33], T3/T7 H7L30.1 (carrying the 7SL gene) [24], pH5SST [34], pBSM13+VA1 [35], and p119MLP(C2A) carrying the Ad2 major late promoter [35] were described previously. pU6/RA.2+U6end-Dsred is a derivative of the pDsRed-Express-DR vector (Clontech) with an insert consisting of the human U6 promoter followed by a cassette corresponding to a piece of beta-globin mRNA cloned in the reverse orientation as in pU6/Hae/RA.2 [33], itself followed by the natural U6 3' end and 3' flanking sequences.
###end p 39
###begin p 40
###xml 4 12 4 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
For in vitro transcription/translation, we used the pCite-2a(+) (Novagen) derived plasmids pNCite/RPC1, pNCite/HsRPC2, pCite/HsRPC62/HA (expressing RPC3), pNCiteBN51 (expressing RPC4), pCite/hu75k3 (expressing RPC5), pCite/RPC39/Flag (expressing RPC6), pCite/HsRPC32/HA (expressing RPC7), pNCite/HsRPC25 (expressing RPC8), pCite/HsCGRP (expressing RPC9), pNCite/HsRPC10stop, pNCite/RPAC1/stop, pNCite/RPAC2, pNCite/HsRPABC2, pNCite/HsRPABC3, pNCite/HsRPABC5, pM3/190III Stop/Bam (expressing SNAP190), pNCite/SNAP50, pNCite/SNAP45, pCite 43-1 (expressing SNAP43), pCite/SNAP19, pCite/B''short#11 (expressing Bdp1), pCite/Brf2, pNCite/Brf1, pCite/hTBP, and pSBet-derived plasmids pSB/Flag/HsRPABC1stop and pSB/flag/RPB12 (expressing RPABC4).
###end p 40
###begin title 41
Glutathione S-transferase (GST) pull-down assays
###end title 41
###begin p 42
###xml 35 39 35 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1-81</sup>
###xml 51 56 51 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1-142</sup>
###xml 137 141 137 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Studier1">[36]</xref>
###xml 320 322 316 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 373 381 369 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 688 696 638 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1047 1056 991 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000134-g002">Figure 2B</xref>
###xml 1082 1084 1026 1028 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 1111 1119 1055 1063 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 75 87 <span type="species:ncbi:511693">E. coli BL21</span>
###xml 411 417 <span type="species:ncbi:9986">rabbit</span>
Recombinant GST, GST-Maf1, GST-Maf11-81 or GST-Maf11-142 were expressed in E. coli BL21 DE3 cells with the T7 system from Studier et al. [36]. The proteins were purified on glutathione Sepharose beads in the presence of 200 microg of RNase A (Sigma) or 5 U/ml of DNase I (Ambion) and the beads were then incubated with [35S] methionine-labeled proteins obtained by coupled in vitro transcription/translation in rabbit reticulocyte lysate (TNT(R) T7 Quick Coupled Transcription/Translation System from Promega). Each binding reaction contained approximately36 microg of GST or approximately70 microg of GST fusion protein immobilized on beads and (approximately3.5-4.1 ng) of radiolabeled in vitro translated protein. The reactions were incubated in phosphate-buffered saline (PBS) supplemented with 0.05% NP40 at 4degreesC for 2 h with constant mixing on a wheel. The beads were then washed with the same buffer and the bound (and input) material fractionated on an SDS-polyacrylamide gel and detected with a Typhoon PhosphorImager (Amersham). In Figure 2B, GST, GST-Maf1, and the [35S] methionine-radiolabeled in vitro translated protein were treated with 100 microg of RNase A (Sigma) or 4 U of DNase I (Ambion) for 20 min at 30degreesC prior to the binding reaction. Proteins were resolved on 12% high-TEMED SDS-polyacrylamide gels.
###end p 42
###begin title 43
Cell culture and transfection
###end title 43
###begin p 44
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 129 135 <span type="species:ncbi:9913">bovine</span>
Human HEK 293 and IMR-90Tert cells were maintained in Dulbecco's modified Eagle medium (DMEM; GIBCO) supplemented with 10% fetal bovine serum, 100 U/ml penicillin, 100 microg/ml streptomycin, and, for the IMR-90Tert cells, 0.1 mM of non-essential amino acids.
###end p 44
###begin p 45
###xml 22 27 <span type="species:ncbi:9606">human</span>
To establish a stable human embryonic kidney 293 cell line expressing HA-tagged Maf1, 293 cells were grown to 50-60% confluency in 10 cm dishes and transfected with 1 microg of pCGN-Maf1 and 100 ng of pY3 (a plasmid conferring hygromycin resistance) complexed with Lipofectamine 2000 (LifeTechnologies). The cells were split 24 h later and kept under hygromycin selection (600 microg/ml) for 21 days. Individual clones were then expanded and tested for HA-Maf1 expression.
###end p 45
###begin p 46
To establish the IMR90-C35 cell line expressing a U6 promoter-directed unstable RNA, IMR-90Tert cells were transfected by the calcium phosphate method with 5 microg of pU6/RA.2+U6end-Dsred. The cells were split 48h later and kept under G418 selection (500 microg/ml) for 21 days. Individual clones were then expanded and tested for expression of the U6 construct. The resulting clonal cell line used here is called the IMR-C35 cell line.
###end p 46
###begin title 47
Antibodies and immunoprecipitations
###end title 47
###begin p 48
###xml 296 301 <span type="species:ncbi:10090">mouse</span>
###xml 310 316 <span type="species:ncbi:9986">rabbit</span>
For immunoprecipitations, we used polyclonal antibodies against RPC1 (CS377), RPC4 (CS682), Maf1 (Ab SZ2793p), GAPDH (Abcam, ab9482) or against the HA tag (clone 12CA5, Roche). RPC1 or RPC4 proteins were detected in western blots by indirect immunostaining with species-specific antibodies (anti-mouse or anti-rabbit, respectively) coupled to Alexa fluorophore (Molecular Probe). HA-tagged proteins were detected directly with anti-HA antibody (clone 3F10, Roche) coupled to HRP.
###end p 48
###begin title 49
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
In vitro transcription assay
###end title 49
###begin p 50
###xml 79 83 79 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Lobo2">[35]</xref>
###xml 188 189 188 189 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 240 242 232 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
VAI, 7SL and S5 transcription reactions were performed as described previously [35] in 10 mM HEPES pH 7.9, 5% glycerol, 50 mM KCl, 0.1 mM EDTA, 1 mM spermidine (Sigma), 1 mM DTT, 5 mM MgCl2, 1 mM each ATP, UTP, GTP, and 10 microC of [alpha-32P] CTP (800 Ci/mmol), in a total reaction volume of 20 microl containing 250 ng of pBSM13+VA1, T3/T7 H7L30.1, or pH5SST supercoiled template and 20 to 30 microg of whole-cell extract. Where indicated, increasing amounts of GST, Maf1, or Brf2 were added to the reaction together with the HeLa extract.
###end p 50
###begin p 51
###xml 3 11 3 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 64 68 64 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Kuhlman1">[37]</xref>
###xml 474 478 458 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Lobo2">[35]</xref>
###xml 579 583 559 563 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8000</sub>
###xml 616 617 596 597 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 706 708 674 676 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
U6 In vitro transcription reactions were performed as described [37] in a total volume of 40 microl containing 100 ng of pU6/Hae/RA.2, 250 ng of poly (dG-dC)*(dG-dC), 2 microl of ATP mix (0.3 M ATP, 10 microg of phosphocreatine kinase per ml and 10 mM creatine kinase) and 4 microl of HeLa whole-cell extract. The resulting RNAs were analyzed by RNase T1 protection and fractionation on 6% polyacrylamide-urea gel. Ad2 ML transcription reactions were performed as described [35]. 400 ng of supercoiled DNA template was transcribed in a total volume of 30 microl containing 1% PEG8000, 1.2 mM O-methyl GTP, 10 mM MgCl2, 1U of RNase T1, 1 mM DTT, 1 mM spermidine, 240 microM ATP and UTP, 0.5 microl of alpha-32P CTP, and 30 microg of whole cell extract.
###end p 51
###begin title 52
siRNA transfection and MMS treatment
###end title 52
###begin p 53
###xml 104 105 104 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
siRNA oligos were designed and synthesized by Qiagen. IMR-90Tert and HEK 293 cells were seeded at 5-8x105 cells per 10 cm plates the day before transfection. 15 microl of INTERFERin transfection reagent (Polyplus) was added to 400 microl of DMEM serum-free medium containing 20 nM of each siRNA oligo, incubated for 10 minutes, and added to the 10 cm plate containing 4 ml of medium. The Negative Control siRNA Alexa fluor-488 (Qiagen) was used as a control and as a marker for transfection efficiency. 36 to 48 hours after transfection, cells were treated with 1 mM MMS for 2 hours followed by three washes, and resuspended in complete DMEM medium. RNA was isolated at different times after MMS treatment as indicated in the figure legends with the TRIzol reagent (Invitrogen) according to the manufacturer's protocol, and used for Northern blot or RNase T1 analysis. Radioactivity was measured on a Typhoon Trio+ imaging system and quantified with the ImageQuant software (Amersham Biosciences).
###end p 53
###begin title 54
Quantitative Polymerase Chain Reaction (qPCR)
###end title 54
###begin p 55
###xml 514 517 502 505 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tyr</sup>
RNA was quantified with a NanaDrop instrument (Nanodrop technologies) and 2 microg were used for reverse transcription with random hexamer primers in the Improm-II reverse transcription system (Promega). 2 microl of the resulting cDNA was amplified with 0.4 microM of 1) the forward primer TGCCCACATCATTGGCAGGATTG and the reverse primer TGAGCGTGGCAATCAGGTAGAAGA to produce a 237 bp long Maf1 fragment; 2) the forward primer CCTTCGATAGCTCAGCTGGT and reverse primer GTCCACAAATGTTTCTACAGG to produce a 58 bp long tRNATyr precursor fragment; 3) the forward primer CATGTTCGTCATGGGTGTGAACCA and the reverse primer AGTGATGGCATGGACTGTGGTCAT to produce a 160 bp long GAPDH fragment. The reactions containing the SensiMix SybrGreen amplification system (Quantace) were set up with a Cas-1200 pipetting robot and analyzed by quantitative PCR on a Rotor-Gene-3000 (Corbett, life science). The thermal cycling conditions were optimized according to the manufacturer's protocol. The results were analyzed with the software provided with the instrument, using the comparative quantification function. The quantification was normalized relative to PCRs performed with cDNA from untreated cells.
###end p 55
###begin title 56
Northern-Blot
###end title 56
###begin p 57
###xml 255 256 251 252 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 331 332 321 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
10-20 microg of RNA was fractionated on a 7% denaturing polyacrylamide gel and transferred onto a Hybond-N+ nylon membrane (Amersham) with the BioRad PAGE and transfer systems. The membrane was incubated in pre-hybridization buffer containing 500 mM NaHPO4 (pH 7.2), 7% SDS, and 5 mM EDTA at 80degreesC during 2-4 hours. About 2x108 cpm of radioactively labeled probe were then added to the prehybridization buffer and the incubation was continued overnight at 50 and 60degreesC for the tRNA and U2 probes, respectively. The resulting radioactive signals were visualized with a Typhoon Trio+ imaging system and quantified with ImageQuant (Amersham Biosciences).
###end p 57
###begin title 58
Dephosphorylation assay
###end title 58
###begin p 59
###xml 715 719 687 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Pillai1">[38]</xref>
###xml 788 792 760 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Maroney1">[39]</xref>
###xml 980 981 942 943 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1018 1019 980 981 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1119 1127 1081 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000134-g005">Figure 5</xref>
###xml 862 866 <span type="species:ncbi:9913">Calf</span>
Nuclear extract was prepared from the 293 cell line expressing the HA-Maf1 fusion protein either untreated or treated with 0.2 microg/ml of Rapamycin for 16 h or 0.5 mM MMS for 2 h. The cells were incubated in lysis buffer (10 mM HEPES [pH 7.9], 100 mM KCl, 1 mM EDTA, 1 mM DTT, and 0.5% NP-40) for 4 min at 4degreesC, mixed vigorously, and centrifuged at 5000 rpm for 1 min at 4degreesC. The nuclear pellets were washed with lysis buffer lacking NP-40, resuspended in 250 mM Tris-HCl [pH 7.9], 100 mM KCl, 1 mM EDTA, 1 mM DTT, 0.5% NP-40, 20% glycerol and mixed on a wheel at 4degreesC for 30 min. The extract was then centrifuged at 10 000 rpm for 30 min at 4degreesC, the supernatant collected and used directly [38]. Alternatively, whole cell extract was prepared as described before [39]. 20 microl of nuclear or whole cell extract was treated with 10 U of Calf Intestine Alkaline Phosphatase (CIAP) (Roche) for 30 min at 37degreesC in 50 mM Tris-HCl (pH 8.0) and 0.1 mM ZnCl2. Phosphatase inhibitors (1.5 mM p-NO2-phenyl-phosphate, 1.5 mM sodium fluoride and 1 mM sodium orthovanadate) were added as indicated in Figure 5. The proteins were then fractionated by 12% SDS-PAGE and tagged Maf1 detected by immunoblotting with an anti-HA antibody.
###end p 59
###begin p 60
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human IMR-90Tert were grown to 50-60% confluency in 10 cm dishes and transfected with 10 microg of the pCGN-derived plasmids complexed with Lipofectamine 2000 (Life Technologies). After 48 h, the cells were treated with 0.2 microg/ml of rapamycin and harvested 72 h post transfection. Small-scale nuclear extract preparation and immunoprecipitations were performed as above except that the IMR-90Tert nuclear extract was treated with 10 U of DNase and phosphatase inhibitors (10 mM Na pyrophosphate, 1 mM Na vanadate and 10 mM Na fluoride). Proteins were resolved on a 12% high-TEMED SDS-polyacrylamide gel, transferred to a membrane, and analysed by western blots with anti-HA conjugated to Alexa800 fluorophore (Rockland).
###end p 60
###begin p 61
We thank Otto Hagenbuchle, who gave considerable help with RNA analyses on the Bioanalyzer, Greg Hannon for the IMR-90Tert cell line, Philippe L'Hote for help with tissue culture, and Pascal Cousin for discussion and help with many of the experiments.
###end p 61
###begin title 62
References
###end title 62
###begin article-title 63
Survey and summary: transcription by RNA polymerases I and III.
###end article-title 63
###begin article-title 64
RNA polymerase III transcription and cancer.
###end article-title 64
###begin article-title 65
Direct regulation of RNA polymerase III transcription by RB, p53 and c-Myc.
###end article-title 65
###begin article-title 66
The RNA polymerase III transcription apparatus.
###end article-title 66
###begin article-title 67
Recruitment of RNA polymerase III to its target promoters.
###end article-title 67
###begin article-title 68
RNA polymerases I and III, growth control and cancer.
###end article-title 68
###begin article-title 69
Repression of RNA polymerase III transcription by the retinoblastoma protein.
###end article-title 69
###begin article-title 70
Mechanistic analysis of RNA polymerase III regulation by the retinoblastoma protein.
###end article-title 70
###begin article-title 71
Retinoblastoma protein disrupts interactions required for RNA polymerase III transcription.
###end article-title 71
###begin article-title 72
The retinoblastoma tumor suppressor protein targets distinct general transcription factors to regulate RNA polymerase III gene expression.
###end article-title 72
###begin article-title 73
Distinct mechanisms for repression of RNA polymerase III transcription by the retinoblastoma tumor suppressor protein.
###end article-title 73
###begin article-title 74
p53 is a general repressor of RNA polymerase III transcription.
###end article-title 74
###begin article-title 75
Several regions of p53 are involved in repression of RNA polymerase III transcription.
###end article-title 75
###begin article-title 76
###xml 43 48 <span type="species:ncbi:9606">human</span>
The p53 tumor suppressor protein represses human snRNA gene transcription by RNA polymerases II and III independently of sequence-specific DNA binding.
###end article-title 76
###begin article-title 77
Maf1 is an essential mediator of diverse signals that repress RNA polymerase III transcription.
###end article-title 77
###begin article-title 78
###xml 73 78 <span type="species:ncbi:4932">yeast</span>
maf1 mutation alters the subcellular localization of the Mod5 protein in yeast.
###end article-title 78
###begin article-title 79
###xml 52 76 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Maf1p, a negative effector of RNA polymerase III in Saccharomyces cerevisiae.
###end article-title 79
###begin article-title 80
###xml 63 68 <span type="species:ncbi:4932">yeast</span>
Signaling repression of transcription by RNA polymerase III in yeast.
###end article-title 80
###begin article-title 81
General repression of RNA polymerase III transcription is triggered by protein phosphatase type 2A-mediated dephosphorylation of Maf1.
###end article-title 81
###begin article-title 82
Dephosphorylation and genome-wide association of Maf1 with Pol III-transcribed genes during repression.
###end article-title 82
###begin article-title 83
Transcription: adjusting to adversity by regulating RNA polymerase.
###end article-title 83
###begin article-title 84
Protein kinase A regulates RNA polymerase III transcription through the nuclear localization of Maf1.
###end article-title 84
###begin article-title 85
Two steps in Maf1-dependent repression of transcription by RNA polymerase III.
###end article-title 85
###begin article-title 86
###xml 57 62 <span type="species:ncbi:9606">human</span>
Upstream sequences modulate the internal promoter of the human 7SL RNA gene.
###end article-title 86
###begin article-title 87
###xml 35 40 <span type="species:ncbi:9606">human</span>
Structure-function analysis of the human TFIIB-related factor II protein reveals an essential role for the C-terminal domain in RNA polymerase III transcription.
###end article-title 87
###begin article-title 88
###xml 4 9 <span type="species:ncbi:9606">human</span>
Two human tyrosine tRNA genes contain introns.
###end article-title 88
###begin article-title 89
###xml 39 44 <span type="species:ncbi:9606">human</span>
The discovery of new intron-containing human tRNA genes using the polymerase chain reaction.
###end article-title 89
###begin article-title 90
###xml 43 48 <span type="species:ncbi:9606">human</span>
Sequences required for 3' end formation of human U2 small nuclear RNA.
###end article-title 90
###begin article-title 91
Upstream and downstream of mTOR.
###end article-title 91
###begin article-title 92
Structural basis of transcription: RNA polymerase II at 2.8 angstrom resolution.
###end article-title 92
###begin article-title 93
Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation.
###end article-title 93
###begin article-title 94
###xml 62 78 <span type="species:ncbi:562">Escherichia coli</span>
Improved high-level expression system for eukaryotic genes in Escherichia coli using T7 RNA polymerase and rare ArgtRNAs.
###end article-title 94
###begin article-title 95
###xml 80 85 <span type="species:ncbi:9606">human</span>
cis-acting elements required for RNA polymerase II and III transcription in the human U2 and U6 snRNA promoters.
###end article-title 95
###begin article-title 96
###xml 24 29 <span type="species:ncbi:9606">human</span>
Genomic organization of human 5 S rDNA and sequence of one tandem repeat.
###end article-title 96
###begin article-title 97
A TBP complex essential for transcription from TATA-less but not TATA-containing RNA polymerase III promoters is part of the TFIIIB fraction.
###end article-title 97
###begin article-title 98
Use of T7 RNA polymerase to direct expression of cloned genes.
###end article-title 98
###begin article-title 99
###xml 115 120 <span type="species:ncbi:9606">human</span>
The general transcription factors IIA, IIB, IIF, and IIE are required for RNA polymerase II transcription from the human U1 small nuclear RNA promoter.
###end article-title 99
###begin article-title 100
Purified U7 snRNPs lack the Sm proteins D1 and D2 but contain Lsm10, a new 14 kDa Sm D1-like protein.
###end article-title 100
###begin article-title 101
Transcription and cap trimethylation of a nematode spliced leader RNA in a cell-free system.
###end article-title 101
###begin article-title 102
Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.
###end article-title 102
###begin article-title 103
###xml 20 25 <span type="species:ncbi:9606">human</span>
###xml 72 96 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Characterization of human RNA polymerase III identifies orthologues for Saccharomyces cerevisiae RNA polymerase III subunits.
###end article-title 103
###begin title 104
Figures and Tables
###end title 104
###begin title 105
###xml 72 81 72 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro.</italic>
Maf1 represses transcription from type I, II, and III pol III promoters in vitro.
###end title 105
###begin p 106
###xml 113 121 113 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 468 476 468 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 571 579 571 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 866 874 866 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 978 986 978 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 1187 1191 1187 1191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Dignam1">[40]</xref>
A) Maf1 represses transcription from the 5S, VAI, and 7SL pol III promoters, but not the Ad2 ML pol II promoter, in vitro. 40, 80, 400, and 800 ng of bacterially produced Maf1 (lanes 3-6) or similar amounts of Brf2 (lanes 7-10) were added to transcription reactions identical to that shown in lane 2. Lane 1 shows unprogrammed transcription extract. B) SDS-polyacrylamide gel stained with coomassie blue indicating the amounts of recombinant Maf1 and Brf2 used in the in vitro transcription experiment described in A. C) Maf1 represses transcription from the U6 promoter in vitro. The lanes are as in A, except that the HeLa cell extract was programmed with the U6 promoter and that increasing amounts of GST rather than Brf2 were added as control. D) SDS-polyacrylamide gel stained with coomassie blue indicating the amounts of recombinant Maf1 and GST used in the in vitro transcription experiment described in C. E) Maf1 associates with pol III in the transcription extract. In vitro transcription reactions containing either no (lane 2) or 400 ng (lane 3) of recombinant His-tagged Maf1 were incubated with Ni-NTA beads, and the beads were then washed several times with D100 buffer [40]. The affinity-purified complex was analysed by SDS-PAGE followed by immunoblotting with anti-RPC1 or anti-His tag antibodies.
###end p 106
###begin title 107
Maf1 associates with pol III, the individual pol III subunits RPC1 and RPAC2, and Brf1.
###end title 107
###begin p 108
###xml 112 116 112 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000134-Hu1">[41]</xref>
###xml 893 901 893 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 948 950 948 950 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 1151 1159 1151 1159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1323 1331 1323 1331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1495 1496 1495 1496 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 1573 1581 1573 1581 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1946 1954 1946 1954 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1979 1983 1979 1983 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1-82</sup>
###xml 1996 2001 1996 2001 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1-142</sup>
###xml 792 799 <span type="species:ncbi:562">E. coli</span>
###xml 1757 1762 <span type="species:ncbi:9606">human</span>
A) Association of endogenous Maf1 with pol III and Brf1. Whole cell extract derived from the HeLa cell line 9-8 [41] was used for immunoprecipitations with anti-Maf1 or anti-GAPDH (Abcam) antibodies. The beads were washed, bound material was then eluted by boiling and used for immunoblotting with an anti-RPC1 antibody (CS377) (upper panel), an anti-Brf1 antibody (CS146) (middle panel) or an anti-Maf1 antibody (SZ2793) (lower panel). Lane 1 shows 1/20 of the input material, lanes 2, 3, and 4 show 1/30 of the flow through, 1/30 of the last wash, and 1/5 of the eluted material, respectively. Quantification of the signal shows that 6% of the RPC1 protein was co-immunoprecipitated with Maf1. B) Association of Maf1 with individual pol III subunits. GST-Maf1 or just GST were expressed in E. coli and immobilized on glutathione sepharose beads. Pol III subunits were synthesized by coupled in vitro transcription/translation in the presence of [35S] methionine, and incubated with GST-Maf1 or GST beads. The beads were washed extensively and the bound material was analysed by SDS-PAGE and autoradiography. The first lane (input) shows 1/10 of the in vitro translated material added to the beads. C) Association of Maf1 with RPC1 and RPAC2 is not mediated by RNA nor DNA. Before the binding reaction, GST, GST-Maf1, and in vitro translated RPC1 and RPAC2 were subjected to RNase A or DNase I treatment as indicated above the lanes. D and E) Association of Maf1 with TFIIIB components and SNAPc subunits, respectively. The experiments were performed as in B but with the in vitro translated proteins indicated. F) Pol III subunits and Brf1 associate with different Maf1 regions. On top, a schematic representation of full-length and truncated versions of human Maf1 are shown, with the A, B, and C conserved regions indicated. The experiment shown in the three bottom panels was performed as in B but with the GST fusion proteins indicated and in vitro translated GST, GST-Maf11-82, or GST-Maf11-142, as indicated.
###end p 108
###begin title 109
Knock-down of endogenous Maf1 increases the levels of unstable tRNA precursors.
###end title 109
###begin p 110
###xml 507 510 503 506 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tyr</sup>
###xml 1170 1173 1162 1165 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leu</sup>
###xml 1197 1200 1189 1192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tyr</sup>
A) Knock-down of endogenous Maf1 in untransformed cells. Exponentially growing IMR-90Tert cells were either left untransfected, or transfected with either siRNAs #2 or #3 against MAF1, or with a control siRNA, as indicated on top of the panel. RNA was then isolated from untransfected or transfected cells and 2 microg of total RNA used for random-primed reverse transcription. The resulting cDNA was analyzed by real-time quantitative PCR (qPCR) with primers corresponding to either Maf1 (black bars), tRNATyr precursor (yellow bars), or GAPDH as a control (blue bars). B) and C) Knock-down of endogenous Maf1 in transformed cells. In B, the levels of either alpha-tubulin as a loading control (upper panel) or Maf1 (lower panel) were analyzed by western-blot in extracts from either untransfected 293 cells (lane 1) or 293 cells transfected with the siRNAs indicated above the lanes (lanes 2-5). In C, 293 cells were either left untransfected (lane 1) or transfected with the siRNAs indicated above the lanes. Cellular RNA was then collected and analyzed by northern blot with a probe detecting U2 snRNA precursors as a control (upper panel), or intron-containing tRNALeu (middle panel) and tRNATyr (bottom panel) precursors.
###end p 110
###begin title 111
Knock-down of endogenous Maf1 results in higher pol III transcription after stress.
###end title 111
###begin p 112
###xml 349 358 349 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000134-g003">Figure 3A</xref>
A) RT-qPCR analysis of Maf1 and GAPDH RNA before (black and blue bars, respectively), and after (grey and white bars, respectively) MMS treatment (1 mM MMS for 2 hours) in IMR-90Tert cells either left untransfected or transfected with siRNAs against Maf1 (#2 and #3), or control siRNA, as indicated on top of the panel. Total RNA was analyzed as in Figure 3A. B) Total RNA from exponentially growing IMR-90Tert cells either left untransfected or transfected with siRNAs against MAF1 (#2 and #3) or a control siRNA, as indicated on top of the panel, were either not treated (lanes 1, 2) or treated (lanes 3-10) with 1 mM MMS for 2 hours. Samples isolated 12 and 15 h after MMS removal are shown, as indicated (lanes 3-10). Equal amounts of total RNA (approximately100 ng/microl) were then resolved on a Bioanalyzer, showing the 18S ribosomal RNA in the top band and short RNAs concentrated in the bottom band. C) Exponentially growing IMR-C35 cells were transfected with siRNA #A2 and #3 against Maf1 or a control siRNA, and then treated or not with 1 mM MMS for 2 hours, as indicated above the lanes. Total RNA was isolated 12-15 hours after MMS removal and 10 microg analyzed by RNase T1 mapping to reveal the transcript derived from the pU6/RA.2+U6end-Dsred integrated construct. Lanes 1 shows a similar RNAse T1 assay performed with RNA from the parental IMR-90Tert cell line. U6-5': signal corresponding to correctly initiated U6/RA.2+U6end RNA.
###end p 112
###begin title 113
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human Maf1 is phosphorylated and becomes dephosphorylated after rapamycin and MMS treatment.
###end title 113
###begin p 114
A) Nuclear extract from a HEK 293 cell line expressing HA-tagged Maf1 either untreated (upper panel), or treated with rapamycin (middle panel) or MMS (lower panel) was incubated with nothing, CIAP with or without phosphatase inhibitors, or phosphatase inhibitors alone, as indicated above the lanes. Tagged Maf1 was visualized with an antibody directed against the HA tag. Lane 5 shows bacterially expressed Maf1, which was loaded on a non-adjacent lane of the same gel. B) Nuclear extract from IMR-90Tert cells transiently expressing HA-tagged Maf1 was prepared in the presence of phosphatase inhibitors prior to immunoprecipitation with affinity-purified anti-RPC1 antibody. Tagged Maf1 was visualized with an antibody directed against the tag (alpha-HA antibody). Only the fastest migrating form of Maf1 bound to pol III. Arrows: phosphorylated Maf1. The negative control was a mock immunoprecipitation performed with protein A sepharose beads without antibody. Lane 1 shows 1/20 of the input material.
###end p 114
###begin p 115
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 115
###begin p 116
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: University of Lausanne, SNSF grant 3100A0-109941/1, NIH grant GM38810
###end p 116

